knowledge -WSS

knowledge

author：hotspot 2025-09-29 22:47:29 - browse：11661

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Paxlovid should be available without a positive Covid test

hotspot

WSS

Amylyx ALS drug failure raises questions and concerns

Biogen shutters digital health group, ends Apple study, in cost cutting move

RSV shot was 90% effective at preventing hospitalizations in kids

How the Dana

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Amylyx ALS drug fails large clinical trial

hotspot

knowledge

leisure time

Apple is now the first public company to be valued at $3 trillion

Change Healthcare payments predicted restored March 15

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: Who gets the credit for GLP

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novo Nordisk obesity pill bests Wegovy in early trial

Wildfire smoke exposes gaps in outdoor worker protections

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Malaria cases in Florida and Texas: Here’s what you need to know

Covid vaccines: Private market messier than government rollout

hotspot

Precocious puberty in girls comes with mental health risks

Change Healthcare cyberattack prompts Medicare loan program

What it’s like to watch children die of measles

Air quality improving but still lags in Black, Hispanic communities

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

How one patient went off dialysis — and others can too

knowledge

hotspot

leisure time

hotspot